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Abstract NLDB (Natural Ligand DataBase; URL: http://
nldb.hgc.jp) is a database of automatically collected and
predicted 3D protein–ligand interactions for the enzymatic
reactions of metabolic pathways registered in KEGG.
Structural information about these reactions is important
for studying the molecular functions of enzymes, however
a large number of the 3D interactions are still unknown.
Therefore, in order to complement such missing informa-
tion, we predicted protein–ligand complex structures, and
constructed a database of the 3D interactions in reactions.
NLDB provides three different types of data resources; the
natural complexes are experimentally determined protein–
ligand complex structures in PDB, the analog complexes
are predicted based on known protein structures in a
complex with a similar ligand, and the ab initio complexes
are predicted by docking simulations. In addition, NLDB
shows the known polymorphisms found in human genome
on protein structures. The database has a flexible search
function based on various types of keywords, and an
enrichment analysis function based on a set of KEGG
compound IDs. NLDB will be a valuable resource for
experimental biologists studying protein–ligand interac-
tions in specific reactions, and for theoretical researchers
wishing to undertake more precise simulations of
interactions.
Keywords Protein–ligand interactions  Docking 
Enzymatic reactions  Variant residues  Database
Introduction
Protein–ligand interactions play key roles in almost all
biological processes, ranging from enzyme catalysis to
signal transduction. The molecular recognition of a ligand
by its host protein requires non-covalent interactions, such
as hydrogen and hydrophobic bonding, between molecules.
Thus, characteristics of these interactions, including the
ligand-binding modes and binding affinities, are valuable
information to facilitate the elucidation of molecular
mechanisms of ligand recognition to understand molecular
functions in vivo.
The large-scale structural information for protein–ligand
interactions is currently available in the Protein Data Bank
(PDB; [2]), and has contributed to the physicochemical
analyses of their interactions. However, this wealth of
information is not still enough to physicochemically
explain all of the enzymatic reactions with the enzymes
that are important potential drug targets [6].
The information about various metabolic pathways and
their related reactions has been manually curated and
stored in the Kyoto Encyclopedia of Genes and Genomes
(KEGG; [7]). In the KEGG REACTION database,
enzymes that catalyze reactions are linked to their struc-
tural information in PDB, if their structures are known and
accessible. However, even if the structure of an enzyme
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catalyzing a reaction of interest is available in PDB, its
structures in a complex with substrates or products in the
reaction are not always experimentally determined. In such
cases, detailed information about the 3D interaction char-
acteristics in natural ligands may not be obtained.
Due to the importance of the information about 3D
protein–ligand interactions for studying the molecular
functions of enzymes, it would be valuable to organize and
complement the missing structural information of the
metabolic pathways with computational approaches. There
are some high-quality databases of biologically relevant
ligands bound to proteins, such as Binding MOAD [1] and
BioLiP [22], however, these databases have not registered
such missing structural data, which can be pre-calculated
with predictions. Therefore, we collected and predicted the
complex structures of protein–ligand interactions by
focusing on the interactions in the reactions of the KEGG
REACTION database, and then constructed the database,
named NLDB (capitals denote Natural Ligand DataBase;
URL: http://nldb.hgc.jp).
NLDB deals with the compounds observed in the KEGG
reactions, and provides three different types of data
resources: natural, analog, and ab initio complexes (Fig. 1;
see ‘‘Materials and methods’’ for details). NLDB provides
a flexible search function, based on various types of
relevant keywords, and an enrichment analysis function
based on a set of KEGG compound IDs. NLDB is a unique,
up-to-date database that not only collects 3D protein–li-
gand interactions from known structures but also auto-
matically predicts complex structures that were previously
unknown.
Materials and methods
Procedure for the NDLB data construction
The NLDB data were constructed through four main steps:
(1) preparation of a list of protein–ligand interactions in
enzymatic reactions (2) collection of natural complex
structures, (3) prediction of analog complex structures, and
(4) prediction of ab initio complex structures (Fig. 1).
Preparation of a list of protein–ligand interactions
in enzymatic reactions
All the reactions in the KEGG REACTION database along
with the KEGG IDs for the metabolic pathways, enzymes
and compounds related to each reaction were obtained
using the KEGG API [7, 8]. In KEGG, the reactions are
Fig. 1 Schematic diagram of the NLDB data construction
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manually curated, and each reaction has information of
reactants (substrates and products). In addition, other IDs
corresponding to each of the enzymes, such as PDB IDs
and UniProt accession numbers, and chemical compound
IDs found in the PDB chemical component dictionary
(PDB-CCD; [21]) for ligands bound to the enzyme, were
also obtained using the same API. Then, these IDs were
merged together, and reactions with enzymes to which
PDB IDs were assigned, i.e. whose structures were known
from the KEGG REACTION database, were selected for
the list for the NLDB data construction. On the other hand,
the other reactions with enzymes to which PDB IDs were
not assigned were not included in the list, and were
immediately registered in NLDB.
The following two clustering processes were then car-
ried out. The first clustering for a set of chemical com-
pounds was done by the chemical similarity scores
(Tanimoto coefficients) between two different compounds,
calculated by the connected maximum common substruc-
ture (C-MCS) search using the fkcombu program [10]. In
C-MCS, the substructures between two small molecules
are defined as a connected graph, and have the same atom
types and bond connections. The Tanimoto coefficient of
0.7 was used as the threshold to define the similar com-
pound groups, because the average RMSD of 3D confor-
mations was reportedly 2.0 A˚ for compound pairs with
more than 0.7 chemical similarity [11]. The second clus-
tering for a set of proteins was done by sequence simi-
larity using the CD-HIT program [13] with the default
sequence identity threshold of 0.9, and with the option of
0.8 for the alignment coverage of a longer sequence. In
each cluster, protein sequences were further aligned using
the clustalw2 program [12], and then locations about their
known ligand-binding residues within 4.5 A˚ from any
atoms of a ligand were shared and mapped between the
aligned sequences.
The two data sets were then merged together, to form
three different types of ligand–protein complex lists: (I) a
list of known protein–ligand complex structures, (II) a list
of known protein-analog complex structures, and (III) a list
of known apo-protein structures. To make the list (III),
proteins with a ratio of missing residues (#missing resi-
dues/#total residues in the protein) of more than 10 % were
removed from the list (III), and a representative protein
structure with the largest sequence length, which precedes
structures with the highest resolution, was selected for each
reaction on the same list.
Collection of natural complex structures
The natural complexes were defined as the complex
experimentally determined and registered in PDB. We used
the word ‘natural’ to distinguish compounds naturally
found in vivo from compounds artificially generated
in vitro. Note that NLDB deals with only the compounds
found in the KEGG REACTION database. According to
the list (I), the coordinates of the ligands in complex with
proteins were extracted from the PDB files.
Prediction of analog complex structures
The analog complexes were protein–ligand complex
structures, predicted based on the structures of protein-
analog interactions according to the list (II). Firstly, the
ideal coordinates of compounds, computed with the
CORINA program, which automatically generates high-
quality and low-energy 3D coordinates for a small mole-
cule [17], were downloaded from the Ligand Expo data-
base [4]. Secondly, a target compound known to bind a
target protein in a reaction was superimposed onto its
analog bound to the protein, using the fkcombu program,
which flexibly transforms a target molecule onto a refer-
ence molecule and is bundled in the KCOMBU package
program for comparison and modelling of chemical struc-
tures [10, 11] (Fig. 2I-B). Finally, the conformation of the
superimposed compound was locally optimized using
AutoDock VINA [18], which is a fast molecular docking
program that can be used for large virtual screening
(Fig. 2I-C). In addition, the program calculated the binding
affinity (VINA docking score) for each binding confor-
mation (pose), and the poses with lower affinities were
considered to be more probable.
Prediction of ab initio complex structures
The ab initio complexes are protein–ligand complex
structures predicted based on the docking simulation,
according to the list (III). The quality for ab initio com-
plexes is largely dependent on the accuracy of the predic-
tions of the binding sites and the initial conformations of
ligands. Thus, we used two different flows to construct
complex structures. When homolog information about the
ligand-binding sites was available, the target compound
was docked onto the binding sites on the target protein
using VINA. When homolog information was not avail-
able, the target-specific ligand-binding sites and the ener-
getically favorable conformations of a target ligand were
predicted using BUMBLE, which predicts them based on
known fragment–fragment interactions observed in PDB
[9] (Fig. 2II-A). BUMBLE reported that the average suc-
cess rate of the conformations with the RMSD of\5.0 A˚
between the native and predicted ligands was 53 % for the
first-ranked-predicted conformations and 70 % in the top
10 conformations in the test for bound structure [9].
However, even though the prediction of the ligand-binding
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sites was reportedly more accurate than AutoDock [14], the
conformations of the compounds built from the predicted
interaction hotspots were still less accurate [9]. Therefore,
the ideal coordinates of the target compound were super-
imposed onto the predicted conformation using the fk-
combu program, and then the aligned conformation was
optimized using VINA, in the same manner as the data
construction of the analog complexes (Fig. 2II-B, C).
Keyword search and enrichment analysis
NLDB provides a flexible keyword search function, enabling
users to retrieve the structures of particular protein–ligand
interactions in reactions of interest. Various types of key-
words are allowed in the search function, such as PDB entry
ID, molecule name, organism, compound name, KEGG
reaction ID, EC number, UniProt accession number,
chemical component ID, rs number, OMIM ID and so on, as
well as combinations of these keywords. In this function,
partial matching is selected by default, so that, for example,
the keyword of ‘GMP’ matches not only a chemical ID but
also protein names. Perfect matching can be achieved as an
option, in this case, for example, the keyword of ‘GMP’
matches only a chemical ID. According to the keywords
inputted in the search box of the NLDB top page, the fol-
lowing three result pages will be provided: (1) The first result
page is a list of reactions with the data counts of three types of
complexes, natural, analog, and ab initio (Fig. 3A). In
addition, in the case when at least one UniProt AC number is
submitted as a keyword, a list of KEGG pathways associated
with their reactions is displayed by switching it to the
‘UniProt Search View’ (Fig. 3B). (2) The second page is a
list of available complex structures for a particular reaction
of interest submitted as a keyword or selected in the first page
(Fig. 3C). The data counts of protein structures with a
specific ligand, substrate or product in each complex type are
shown in the top table, and the lists of different types of
complex structures are also shown, in different tables. The
binding affinities for each analog or ab initio complex
structure are also shown in the Table. (3) The third page
shows the detailed information of a specific protein–ligand
complex structure (Fig. 4). On this page, a list of interacting
residues within 5.0 A˚ from the ligand atoms is shown in the
‘Interaction Residues’ table, and the complex structure is
also visually displayed in the JSmol panel, in the top left-
hand corner. For human proteins, variants including human
polymorphisms and disease-associated mutations are also
shown in the ‘Variants’ table, and are highlighted if there are
variants in the binding site of the protein. The data set of
variants with sequence positions and variation types, poly-
morphisms or disease associate mutations, is collected in
humsavar.txt, which is an index of manually curated variants
from UniProtKB/Swiss-Prot, and downloaded from UniProt
[19]. Other detailed information about the reaction, the
molecule, and the compound is also shown and linked to the
external databases, such as KEGG, PDBj and UniProt.
NLDB also provides an enrichment analysis of a set of
KEGG compounds. This function enables users to retrieve
enriched KEGG pathways with expected p-values. In
addition, a list of the reactions in each enriched pathway is
also shown, in the same table format as that in the first
result page of the keyword search.
An example: complementation of missing complex
structures
NLDB can be used to complement the missing complex
structures in chemical reactions as in the following
example.
Bisphosphoglycerate mutase (BPGM; EC: 5.4.2.4) is an
erythrocyte-specific enzyme, and its main function is to
regulate the oxygen affinity of hemoglobin by controlling
the synthesis of 2.3-bisphosphoglycerate (DG2; C3 H8 O10
P2), which is an allosteric effector of hemoglobin, via a
phosphoryl transfer reaction [15, 20]. The deficiency of
bFig. 2 Procedure for predictions of analog and ab initio complexes.
(I) A complex structure of 3VEY-A and ATP (adenosine 50-
triphosphate; C10H16N5O13P3) in KEGG reaction: R00299 is pre-
dicted, based on the complex structure of 3VEY-A and AGS-503
(Phosphothiophosphoric acid-adenylate ester; C10H16N5O12P3S). The
chemical similarity score calculated based on C-MCS is 0.94. A The
complex structure of 3VEY-A and AGS-503 is used as the template
for the construction of a new 3VEY-A and ATP complex structure.
B An ATP (green) is aligned with AGS-503, using the fkcombu
program. The aligned conformation of ATP has the binding affinity
(VINA docking score) of -2.24 (kcal/mol). C The aligned confor-
mation of ATP (purple) is optimized using VINA, with the local
optimization option. The optimized conformation of ATP has the
binding affinity of -6.07 (kcal/mol). In addition, the optimized
conformation of ATP superimposed onto AGS-503 is shown in D, for
reference only. (II) An ab initio complex structure of bisphospho-
glycerate mutase (PDB ID: 2A9 J-AB) and X15 (1.3-Bisphospho-
glyceric acid; C3 H8 O10 P2) in KEGG reaction: R01662 is
predicted, according to the following steps: A Interaction hotspots are
predicted, and then the energetically favorable conformations of X15
in the predicted hot spots are also predicted, using BUMBLE. B The
ideal coordinates of X15 (green) are aligned with the predicted
conformation, using the fkcombu program. The aligned conformation
of X15 has the binding affinity of 2.01 (kcal/mol). C The aligned
conformation of X15 (purple) is optimized using VINA, with the
local optimization option. The optimized conformation of X15 has the
binding affinity of -5.08 (kcal/mol). D The superimposition of the
optimized conformation of X15 onto its product, DG2 (2.3-Diphos-
phoglyceric acid; C3 H8 O10 P2), cocrystallized with the same
protein (PDB ID: 4H4Z-AB), is shown for reference only
NLDB: a database for 3D protein–ligand interactions in enzymatic reactions 105
123
106 Y. Murakami et al.
123
BPGM (BPGMD) increases the hemoglobin oxygen affin-
ity, leading to a decrease in the DG2 concentration, and is
characterized by hemolytic anemia [3]. There are three
relevant reactions catalyzed by BPGM in the KEGG
REACTION database, and they can be searched with the
keywords ‘bisphosphoglycerate mutase’ in NLDB (KEGG
reaction IDs; R01516, R01518 and R01662). In particular,
BPGM in the complex with 1,3-bisphosphoglycerate (X15;
C3 H8 O10 P2) in R01662, which is the main function of
BPGM, to convert X15 to DG2, is unknown in PDB. This
missing complex structure would be strongly required, for
clarifying the binding mode of the ligand and also for
identifying key residues in the reaction. In the case of
BPGM with X15, there are no analog complexes in which
a ligand similar to X15 binds. In addition, the chemical
similarity score between X15 and DG2, based on C-MCS,
is 0.43. Thus, the ab initio complex structure was predicted,
according to our data construction procedure (Fig. 2II).
The final conformation of X15 bound to BPGM (PDB ID:
2A9 J-AB) is shown in Fig. 2II-D. Note that water atoms
are not considered in the docking calculation, even though
water molecules can enhance ligand stability and activity,
by forming hydrogen bonds or water bridges. As a conse-
quence, X15 was predicted to have a docking pose on the
same binding pocket as DG2, with a low binding affinity of
-5.08 (kcal/mol) (Fig. 2II-C, D). Furthermore, it was
observed that X15 forms two hydrogen bonds with one of
the variant residues of BPGMD, ARG-62, as well as a
hydrogen bond with CYS-23, which is considered to have a
large effect on the reactivity of BPGM [16]. Moreover,
ARG-90, which is a variant with a large effect on the
stability of the protein [5], participated in the binding.
While this ab initio complex structure of BPGM and X15 is
reasonable, in terms of the binding affinity and the binding
mode, it represents a starting point for further detailed
analyses to evaluate the stability of the predicted pose,
considering the effects of both the protein flexibility and
water solvation.
Discussion and conclusions
NLDB is a unique, up-to-date database that collects 3D
protein–ligand interactions from known structures, and also
automatically predicts missing complex structures using
reliable, state-of-the-art software programs, in the reactions
of the KEGG REACTION database. As far as we know,
there are no comparable databases focused on protein–li-
gand complex structures involved in these reactions.
NLDB registers 68,551 natural, 28,441 analog and
64,204 ab initio complexes, for 3248 KEGG reactions in
which 1654 enzymes are involved, and also registers 4379
KEGG reactions in which 3291 enzymes without structural
information are involved (As of July 2016). In total, 7627
reactions have been registered in NLDB. Furthermore,
1679 and 2131 entries with variant residues in their binding
sites linked to rs number and OMIM ID, respectively, are
registered and viewed in the ‘Variants’ page. The former
entries are associated with 89 pathways and 367 reactions,
and the latter entries are associated with 103 pathways and
354 reactions.
Even though experimentally determined complex
structures; i.e., natural complexes, cover only 19.09 %
(1456/7627) and 21.66 % (1652/7627) of all registered
reactions, which have at least one known protein structure
in a complex with a substrate and a product, respectively,
the current coverage of 3D protein–ligand interactions in
NLDB is 35.23 % (2687/7627) and 21.19 % (2885/7627)
of these reactions, which have at least one known or pre-
dicted protein structure in a complex with a substrate and a
product, respectively (Table 1). These numbers were
obtained by checking whether at least one known or pre-
dicted protein structure in a complex with a substrate or a
product exists in each reaction. In addition, NLDB can
provide the predicted structures of protein–ligand interac-
tions with binding affinities of B-3.0 for about 22 % of
the registered reactions, and those with binding affinities of
B-5.0 for about 13 % of the registered reactions.
In particular, we believe that these predicted structures
with lower binding affinity can provide some insights for
experimental biologists studying protein–ligand interac-
tions in specific chemical reactions, in which the 3D
structures of the interaction are as yet unknown, and will
facilitate breakthroughs in understanding or verifying
chemical reactivities at specific ligand-binding sites, as
shown in the above example. Furthermore, NLDB will be a
starting point for theoretical researchers wishing to
undertake more accurate simulations of the ligand-binding
affinity and stability in the predicted conformation of a
complex, by considering the effects of protein flexibility
and water solvation. Therefore, NLDB will be continually
improved, for the prediction of more accurate structures
bFig. 3 Examples of a keyword search in NDLB. A When a set of
keywords, for example, ‘hexokinase, homo sapiens’ is inputted in the
search box of the NLDB top page, a list of the reactions with the data
counts of three types of complex structures, natural, analog, and
ab initio is obtained. B In addition, in the case when at least one
UniProt AC number (e.g. ‘P19367’) is also inputted in the search box,
a list of KEGG pathways associated with their reactions is displayed
by switching it to the ‘UniProt Search View’. C Then, lists of the
available complex structures for the reaction selected in the result
page A or B, e.g. ‘R00760’ in the row surrounded by a red square on
page A, are obtained. The different types of structures in complex
with a substrate and a product are shown in different tables. In
addition, when the input keywords include a KEGG reaction ID or
when only a KEGG reaction ID is inputted, then page B will be
directly accessed, without going through page A
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Fig. 4 An example of the search results page of a protein–ligand complex
structure. A list of interacting residues within 5.0 A˚ from the ligand atoms
is shown in the ‘Interaction Residues’ table, and the complex structure is
also visually displayed in the JSmol panel, in the top left-hand corner. For
human proteins, variants including human polymorphisms and disease-
associated mutations are also shown in the ‘Variants’ table, and are
highlighted if there are variants in the binding site of the protein. In this
example of the analog complex of 1DGK-N and ATP, a variant residue,
680-THR in chain N, located in the binding site is specified in the table of
interaction residues (highlighted in pink). Other detailed information about
the reaction, the molecule, and the compound is also shown and linked to
the external databases, such as KEGG, PDBj and UniProt
108 Y. Murakami et al.
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involved in reactions and for web interface usability.
NLDB is freely accessible at http://nldb.hgc.jp, and will be
regularly updated every 3 months.
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